Fujiwara M, Anstadt EJ, Khanna KM, Clark RB. Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720. Clinical Immunology. 2015 May;158(1):103–13. doi: 10.1016/j.clim.2015.03.018.